Accelerate Diagnostics Inc expected to post a loss of 33  cents a share - Earnings Preview

Accelerate Diagnostics

06/05/2021 07:50

* Accelerate Diagnostics Inc  AXDX.OQ   AXDX.O  is expected
to show a rise in quarterly revenue when it reports results .
* The Tucson, Arizona-based company is expected to report   a
32.2% increase in revenue to $3.096 million from $2.34 million a
year ago, according to the mean estimate from 5 analysts, based
on Refinitiv data. 
​* Refinitiv's mean analyst estimate for Accelerate Diagnostics
Inc is for a loss of 33 cents per share. For the same quarter
last year, the company reported a loss of 39 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Accelerate
Diagnostics Inc is $12​, about 39.4% above​ its last closing
price of $7.27. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Dec. 31 2020  -0.32       -0.32      -0.33     Missed  -2.5
 Sep. 30 2020  -0.33       -0.33      -0.33     Met     1.2
 Jun. 30 2020  -0.34       -0.34      -0.35     Missed  -2.9​
 Mar. 31 2020  -0.39       -0.38      -0.39     Missed  -1.3
 Dec.          -0.40​      -0.40      -0.39     Beat    3.7​
 31​ 2019​                                              
 Sep. 30 2019  -0.35       -0.38      -0.37     Beat    2.6​
 Jun. 30 2019  -0.38       -0.39      -0.38     Beat    1.6
 Mar. 31 2019  -0.42       -0.41      -0.40     Beat    3.4
 This summary was machine generated May 6 at 06:50 GMT.  All
figures in US dollars unless otherwise stated